These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34108312)

  • 1. [Chronic-phase chronic myeloid leukemia with intracranial hemorrhage complicated with tumor lysis syndrome].
    Oyama C; Arakawa Y; Ikeda Y; Aoki T; Kubota Y; Isobe K; Mori M; Kurihara J; Koh K
    Rinsho Ketsueki; 2021; 62(5):346-351. PubMed ID: 34108312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sudden Intracranial Hemorrhage in a Patient With Atypical Chronic Myeloid Leukemia in Chronic Phase.
    Kouzuki K; Umeda K; Saida S; Kato I; Hiramatsu H; Funaki T; Kanda K; Muramatsu H; Yoshida K; Ogawa S; Adachi S
    J Pediatr Hematol Oncol; 2018 Nov; 40(8):e553-e556. PubMed ID: 29227326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous tumor lysis syndrome in a patient with chronic myeloid leukemia treated successfully with allopurinol.
    Gartenberg A; Winkel M; Leonard N
    Am J Emerg Med; 2024 Apr; 78():242.e1-242.e3. PubMed ID: 38007380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor lysis syndrome soon after treatment with hydroxyurea followed by nilotinib in two patients with chronic-phase chronic myelogenous leukemia.
    Hua J; Iwaki Y; Inoue M; Hagihara M
    Int J Hematol; 2013 Aug; 98(2):243-6. PubMed ID: 23649869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group.
    Hehlmann R; Heimpel H; Hasford J; Kolb HJ; Pralle H; Hossfeld DK; Queisser W; Löffler H; Hochhaus A; Heinze B
    Blood; 1994 Dec; 84(12):4064-77. PubMed ID: 7994025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute tumor lysis syndrome in a patient with chronic myelogenous leukemia in blast crisis: role of high-dose Ara-C.
    Przepiorka D; Gonzales-Chambers R
    Bone Marrow Transplant; 1990 Oct; 6(4):281-2. PubMed ID: 2085702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial Hemorrhage in a Pediatric Patient with Chronic Myeloid Leukemia in Chronic Phase: A Case Report.
    Takahashi N; Sano H; Mochizuki K; Kobayashi S; Ohara Y; Kikuta A
    Case Rep Oncol; 2021; 14(1):525-530. PubMed ID: 33976629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of non-Hodgkin lymphoma in a patient with chronic myeloid leukemia.
    Găman AM; Dobrea C; Rotaru I
    Rom J Morphol Embryol; 2013; 54(4):1141-5. PubMed ID: 24399014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pure red cell aplasia occurring during the course of chronic myelogenous leukemia].
    Yasuyama M; Kawauchi K; Takei K; Ogasawara T; Ohkawa S
    Rinsho Ketsueki; 2004 Jan; 45(1):66-71. PubMed ID: 14999937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
    Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
    Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea and splenic irradiation-induced tumour lysis syndrome: a case report and review of the literature.
    Chen SW; Hwang WS; Tsao CJ; Liu HS; Huang GC
    J Clin Pharm Ther; 2005 Dec; 30(6):623-5. PubMed ID: 16336296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement].
    Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Mori H; Niikura H; Omine M; Fujita K
    Rinsho Ketsueki; 1997 Aug; 38(8):663-68. PubMed ID: 9311272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group.
    Hehlmann R; Heimpel H; Hasford J; Kolb HJ; Pralle H; Hossfeld DK; Queisser W; Löffler H; Heinze B; Georgii A
    Blood; 1993 Jul; 82(2):398-407. PubMed ID: 8329700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.
    Cohen MH; Johnson JR; Pazdur R
    Clin Cancer Res; 2005 Jan; 11(1):12-9. PubMed ID: 15671523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor lysis syndrome.
    Ezzone SA
    Semin Oncol Nurs; 1999 Aug; 15(3):202-8. PubMed ID: 10461705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of life-threatening pulmonary leukostasis with single agent imatinib mesylate during CML myeloid blast crisis.
    Leis JF; Primack SL; Schubach SE; Curtin PT; Druker BJ; Maziarz RT
    Haematologica; 2004 Sep; 89(9):ECR30. PubMed ID: 15377482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
    Qing X; Qing A; Ji P; French SW; Mason H
    Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and treatment of tumor lysis syndrome in patients with acute leukemia.
    Razis E; Arlin ZA; Ahmed T; Feldman EJ; Puccio C; Cook P; Chun HG; Helson L; Mittelman A
    Acta Haematol; 1994; 91(4):171-4. PubMed ID: 7976113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic myelogenous leukemia in the chronic phase with lymph node swelling which represented extramedullary involvement composed of cells at different stages of maturation.
    Kobayashi Y; Tanaka T; Kawata E; Akaogi T
    Rinsho Byori; 2011 Apr; 59(4):360-3. PubMed ID: 21618900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone marrow aplasia without blast crisis in a case of CML of 10-year survival].
    Shiga Y; Yokoyama A; Ishibashi T; Shichishima T; Abe R; Yui T; Kimura H; Matsuda S; Uchida T; Kariyone S
    Rinsho Ketsueki; 1989 May; 30(5):752-6. PubMed ID: 2795887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.